Clinical trial
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
NCT07321899 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 11, 2026
- Completion date
- April 30, 2041
- Enrollment
- 1,186 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
severe tricuspid regurgitation